121 related articles for article (PubMed ID: 37723964)
21. Multi-Omics Prognostic Signatures Based on Lipid Metabolism for Colorectal Cancer.
Sun Y; Liu B; Chen Y; Xing Y; Zhang Y
Front Cell Dev Biol; 2021; 9():811957. PubMed ID: 35223868
[No Abstract] [Full Text] [Related]
22. Improving the overall survival prognosis prediction accuracy: A 9-gene signature in CRC patients.
Zheng W; Lu Y; Feng X; Yang C; Qiu L; Deng H; Xue Q; Sun K
Cancer Med; 2021 Sep; 10(17):5998-6009. PubMed ID: 34346563
[TBL] [Abstract][Full Text] [Related]
23. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
[TBL] [Abstract][Full Text] [Related]
24. A novel Anoikis and immune-related genes marked prognostic signature for colorectal cancer.
Cai Z; Zhou F
Medicine (Baltimore); 2022 Nov; 101(46):e31127. PubMed ID: 36401385
[TBL] [Abstract][Full Text] [Related]
25. Prognosis analysis of necroptosis-related genes in colorectal cancer based on bioinformatic analysis.
Liang X; Cheng Z; Chen X; Li J
Front Genet; 2022; 13():955424. PubMed ID: 36046241
[No Abstract] [Full Text] [Related]
26. A novel prognostic signature of immune-related genes for patients with colorectal cancer.
Wang J; Yu S; Chen G; Kang M; Jin X; Huang Y; Lin L; Wu D; Wang L; Chen J
J Cell Mol Med; 2020 Aug; 24(15):8491-8504. PubMed ID: 32564470
[TBL] [Abstract][Full Text] [Related]
27. An immune-related gene prognostic index for predicting prognosis in patients with colorectal cancer.
Li C; Wirth U; Schardey J; Ehrlich-Treuenstätt VV; Bazhin AV; Werner J; Kühn F
Front Immunol; 2023; 14():1156488. PubMed ID: 37483596
[TBL] [Abstract][Full Text] [Related]
28. Exploration and validation of a combined immune and metabolism gene signature for prognosis prediction of colorectal cancer.
Xiao Y; Zhang G; Wang L; Liang M
Front Endocrinol (Lausanne); 2022; 13():1069528. PubMed ID: 36518242
[TBL] [Abstract][Full Text] [Related]
29. Exploration of prognosis and immunometabolism landscapes in ER+ breast cancer based on a novel lipid metabolism-related signature.
Shen L; Huang H; Li J; Chen W; Yao Y; Hu J; Zhou J; Huang F; Ni C
Front Immunol; 2023; 14():1199465. PubMed ID: 37469520
[TBL] [Abstract][Full Text] [Related]
30. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma.
Dai K; Liu C; Guan G; Cai J; Wu L
BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781
[TBL] [Abstract][Full Text] [Related]
31. Development of an Immune Infiltration-Related Eight-Gene Prognostic Signature in Colorectal Cancer Microenvironment.
Wu B; Tao L; Yang D; Li W; Xu H; He Q
Biomed Res Int; 2020; 2020():2719739. PubMed ID: 32908876
[TBL] [Abstract][Full Text] [Related]
32. Lipid metabolism-related gene signature predicts prognosis and depicts tumor microenvironment immune landscape in gliomas.
Li J; Zhang S; Chen S; Yuan Y; Zuo M; Li T; Wang Z; Liu Y
Front Immunol; 2023; 14():1021678. PubMed ID: 36860853
[TBL] [Abstract][Full Text] [Related]
33. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients.
Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357
[TBL] [Abstract][Full Text] [Related]
34. Construction and Validation of a Novel Ferroptosis-Related lncRNA Signature to Predict Prognosis in Colorectal Cancer Patients.
Zhang W; Fang D; Li S; Bao X; Jiang L; Sun X
Front Genet; 2021; 12():709329. PubMed ID: 34777458
[No Abstract] [Full Text] [Related]
35. Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer.
Luan L; Dai Y; Shen T; Yang C; Chen Z; Liu S; Jia J; Li Z; Fang S; Qiu H; Cheng X; Yang Z
Front Immunol; 2022; 13():951455. PubMed ID: 36189298
[TBL] [Abstract][Full Text] [Related]
36. Characteristics of endoplasmic reticulum stress in colorectal cancer for predicting prognosis and developing treatment options.
Geng J; Guo Y; Xie M; Li Z; Wang P; Zhu D; Li J; Cui X
Cancer Med; 2023 May; 12(10):12000-12017. PubMed ID: 36999888
[TBL] [Abstract][Full Text] [Related]
37. Development and Validation of a TNF Family-Based Signature for Predicting Prognosis, Tumor Immune Characteristics, and Immunotherapy Response in Colorectal Cancer Patients.
Xiao Z; Nie K; Han T; Cheng L; Zhang Z; Peng W; Shi D
J Immunol Res; 2021; 2021():6439975. PubMed ID: 34541005
[TBL] [Abstract][Full Text] [Related]
38. Prognosis analysis and validation of lipid metabolism-associated lncRNAs and tumor immune microenvironment in bladder cancer.
Tan Z; Fu S; Zuo J; Wang J; Wang H
Aging (Albany NY); 2023 Aug; 15(16):8384-8407. PubMed ID: 37632832
[TBL] [Abstract][Full Text] [Related]
39. Development and validation of cuproptosis-related lncRNA signatures for prognosis prediction in colorectal cancer.
Pang L; Wang Q; Wang L; Hu Z; Yang C; Li Y; Wang Z; Li Y
BMC Med Genomics; 2023 Mar; 16(1):58. PubMed ID: 36949429
[TBL] [Abstract][Full Text] [Related]
40. Blood cholesterol-to-lymphocyte ratio as a novel prognostic marker to predict postoperative overall survival in patients with colorectal cancer.
Zhou S; He Q; Sheng N; Gong J; Ren J; Wang Z
World J Surg Oncol; 2022 Jan; 20(1):18. PubMed ID: 35033097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
